Pavan Cheruvu
Director · Retension Pharmaceuticals, Inc.
Individual
- 2026
- Oct 13, 2026
- 1
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Pavan Cheruvu files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Eric L. Keller - $250K in RTSN purchases and sales in the last 12 months
- Franklin M. Berger - $120K in RTSN purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Pavan Cheruvu?
Pavan Cheruvu is a corporate insider, tracked as Director of Retension Pharmaceuticals, Inc. (RTSN). InsiderAlpha holds 1 primary Form 4 filing for them, the earliest from 2026, updated as new SEC EDGAR filings are processed.
How many SEC Form 4 filings has Pavan Cheruvu submitted recently?
1 primary Form 4 filing in the last 90 days, covering 1 company.